Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads

► To generate novel and potent lead molecules using 3D-QSAR and Pharmacophore models. ► Knowledge based models to design HIV reverse transcriptase inhibitors. ► Docking studies to reduce the number of false positives.